These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26748052)

  • 21. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist.
    Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Monn JA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):175-80. PubMed ID: 9750002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.
    Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Mayne NG; Wu S; Cockerman SL; Burnett JP; Belegaje R; Bleakman D; Monn JA
    Neuropharmacology; 1997 Jan; 36(1):1-11. PubMed ID: 9144636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s).
    Johnson MP; Barda D; Britton TC; Emkey R; Hornback WJ; Jagdmann GE; McKinzie DL; Nisenbaum ES; Tizzano JP; Schoepp DD
    Psychopharmacology (Berl); 2005 Apr; 179(1):271-83. PubMed ID: 15717213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Pharmacological Characterization of C4
    Monn JA; Henry SS; Massey SM; Clawson DK; Chen Q; Diseroad BA; Bhardwaj RM; Atwell S; Lu F; Wang J; Russell M; Heinz BA; Wang XS; Carter JH; Getman BG; Adragni K; Broad LM; Sanger HE; Ursu D; Catlow JT; Swanson S; Johnson BG; Shaw DB; McKinzie DL; Hao J
    J Med Chem; 2018 Mar; 61(6):2303-2328. PubMed ID: 29350927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
    Fell MJ; Svensson KA; Johnson BG; Schoepp DD
    J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes.
    Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):546-54. PubMed ID: 11138847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R; Golding N; Challiss RA
    Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
    Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
    J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.
    Schaffhauser H; Richards JG; Cartmell J; Chaboz S; Kemp JA; Klingelschmidt A; Messer J; Stadler H; Woltering T; Mutel V
    Mol Pharmacol; 1998 Feb; 53(2):228-33. PubMed ID: 9463480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
    Odagaki Y; Kinoshita M; Toyoshima R
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.
    Hiyoshi T; Marumo T; Hikichi H; Tomishima Y; Urabe H; Tamita T; Iida I; Yasuhara A; Karasawa J; Chaki S
    J Pharmacol Exp Ther; 2014 Dec; 351(3):642-53. PubMed ID: 25277141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and metabotropic glutamate receptor activity of S-oxidized variants of (-)-4-amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: identification of potent, selective, and orally bioavailable agonists for mGlu2/3 receptors.
    Monn JA; Massey SM; Valli MJ; Henry SS; Stephenson GA; Bures M; Hérin M; Catlow J; Giera D; Wright RA; Johnson BG; Andis SL; Kingston A; Schoepp DD
    J Med Chem; 2007 Jan; 50(2):233-40. PubMed ID: 17228865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.
    Gewirtz JC; Chen AC; Terwilliger R; Duman RC; Marek GJ
    Pharmacol Biochem Behav; 2002 Sep; 73(2):317-26. PubMed ID: 12117585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structures.
    Monn JA; Prieto L; Taboada L; Pedregal C; Hao J; Reinhard MR; Henry SS; Goldsmith PJ; Beadle CD; Walton L; Man T; Rudyk H; Clark B; Tupper D; Baker SR; Lamas C; Montero C; Marcos A; Blanco J; Bures M; Clawson DK; Atwell S; Lu F; Wang J; Russell M; Heinz BA; Wang X; Carter JH; Xiang C; Catlow JT; Swanson S; Sanger H; Broad LM; Johnson MP; Knopp KL; Simmons RM; Johnson BG; Shaw DB; McKinzie DL
    J Med Chem; 2015 Feb; 58(4):1776-94. PubMed ID: 25602126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.
    Gilmour G; Broad LM; Wafford KA; Britton T; Colvin EM; Fivush A; Gastambide F; Getman B; Heinz BA; McCarthy AP; Prieto L; Shanks E; Smith JW; Taboada L; Edgar DM; Tricklebank MD
    Neuropharmacology; 2013 Jan; 64():224-39. PubMed ID: 22884720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
    Lea PM; Wroblewska B; Sarvey JM; Neale JH
    J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
    Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
    Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.